info icon

Carcinoma in situ of bronchus and lung

CD2_INSITU_BRONCHUSLUNG

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector
diagram bullet

Check conditions

not C3_BRONCHUS_LUNG

422659

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D02.2&
Hospital discharge: ICD-9 2312
Cause of death: ICD-10 D02.2&
Cause of death: ICD-9 2312
Cancer registry: Topography ICD-O-3 C34
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes 2

3 out of 7 registries used, show all original rules.

26

diagram downward connector

Check minimum number of events None

26

diagram downward connector

Include endpoints None

26

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

26

diagram downward connector
CD2_INSITU_BRONCHUSLUNG

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF9
Parent code in ICD-10 D02
Name in latin Carcinoma in situ mammae

Similar endpoints

List of similar endpoints to Carcinoma in situ of bronchus and lung based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 26 8 18
Unadjusted prevalence (%) 0.01 0.00 0.01
Mean age at first event (years) 69.09 71.76 67.90

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_INSITU_BRONCHUSLUNG – Carcinoma in situ of bronchus and lung
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Carcinoma in situ of bronchus and lung

Endpoint not on priority list, no data to show.